 |
|
|
Discovery
of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric
Modulator Clinical Candidate Targeting Schizophrenia |
| |
| Authors: | Susana Conde-Ceide,Carlos
M. Martínez-Viturro,Jesús Alcázar,Pedro M. Garcia-Barrantes,Hilde Lavreysen,Claire Mackie,Paige N. Vinson,Jerri
M. Rook,Thomas M. Bridges,J. Scott Daniels,Anton Megens,Xavier Langlois,Wilhelmus H. Drinkenburg,Abdellah Ahnaou,Colleen M. Niswender,Carrie
K. Jones,Gregor J. Macdonald,Thomas Steckler,P. Jeffrey Conn,Shaun
R. Stauffer,José Manuel Bartolomé-Nebreda,Craig W. Lindsley |
| |
| Abstract: | | |
| Keywords: | Positive allosteric modulator (PAM) metabotropicglutamatereceptor 5 (mGlu5) 4 5 6 7-tetrahydrooxazolo[5 4-c]pyridine VU0409551 JNJ-46778212 schizophrenia |
|
|